A new application about 141-12-8

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 141-12-8, Recommanded Product: (Z)-3,7-Dimethylocta-2,6-dien-1-yl acetate.

Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. In an article, author is Yokoyama, Takeshi, once mentioned the application of 141-12-8, Name is (Z)-3,7-Dimethylocta-2,6-dien-1-yl acetate, molecular formula is C12H20O2, molecular weight is 196.286, MDL number is MFCD00063205, category is esters-buliding-blocks. Now introduce a scientific discovery about this category, Recommanded Product: (Z)-3,7-Dimethylocta-2,6-dien-1-yl acetate.

Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments

Transthyretin (TTR) is a homotetrameric protein in human plasma. The dissociation of the TTR tetramer and misfolding of the TTR monomer result in the formation of amyloid fibrils. Hereditary TTR amyloidosis is characterized by the extracellular deposition of amyloid fibrils containing TTR variants. The development of small molecules that kinetically stabilize the TTR tetramer is one of the effective strategies for the treatment of hereditary TTR amyloidosis. So far, several stabilizers have been discovered. Tafamidis is the only approved stabilizer for treatment of hereditary TTR amyloidosis, although two nucleic acid medicines that inhibit TTR synthesis, inotersen and patisiran, were recently approved for treatment of this disorder. In this Perspective, we seek to describe the representative kinetic stabilizers from discovery to development, interweaving the crystallographic study of the complex structures.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 141-12-8, Recommanded Product: (Z)-3,7-Dimethylocta-2,6-dien-1-yl acetate.